Business Context and Reporting Period
Surgery Partners, Inc. (SGRY) filed a Current Report on Form 8-K dated December 16, 2025. The filing reports the entry into a material definitive agreement and the creation of a direct financial obligation by the Company's wholly-owned subsidiary, Surgery Center Holdings, Inc.
Key Financial Metrics and Transaction Details
- Debt Issuance: Issued an additional $425.0 million aggregate principal amount of 7.250% Senior Notes due 2032.
- Interest Rate: 7.250% per annum.
- Maturity Date: 2032.
- Existing Debt: The new notes are fungible with $800.0 million of existing 7.250% Senior Notes due 2032 issued on April 10, 2024.
- Total Series Outstanding: Following this issuance, the total outstanding principal for this series is $1.225 billion.
- Revenue, Profit, and Cash Flow: The filing text does not provide specific values for revenue, profit, cash flow, or operating margins.
- Liquidity: The filing text does not provide specific liquidity ratios or cash balance figures.
Material Changes
The primary material change is the expansion of the Company's long-term debt capacity. The new issuance increases the total principal amount of the 2032 Senior Notes series by 53.1% (from $800.0 million to $1.225 billion). The new notes share identical terms with the existing notes and are treated as a single series.
Guidance, Outlook, and Risks
- Management Commentary: The filing confirms the notes will be fungible for U.S. federal income tax purposes with existing notes, except for those issued under Regulation S, which will trade separately under a different CUSIP number until 40 days after the issue date.
- Legal Obligations: The transaction was executed via a Third Supplemental Indenture with Wilmington Trust, National Association, as trustee.
- Risks and Contingencies: The filing does not explicitly detail new risks or contingencies beyond the standard obligations associated with the Senior Notes, which are incorporated by reference from the Base Indenture.
- Guidance: No forward-looking financial guidance or operational outlook is provided in this specific filing.
Investor Verification Checklist
- Verify the total outstanding debt load of $1.225 billion for the 2032 Senior Notes series.
- Confirm the interest expense impact of the additional $425.0 million at a 7.250% coupon rate.
- Review the full text of the Third Supplemental Indenture (Exhibit 4.1) for specific covenants and restrictions.
- Monitor the trading status of Regulation S notes, which will trade separately for 40 days post-issuance.
- Assess the Company's liquidity position in light of the increased debt service obligations.